Categories: News

NYSE Content Advisory: Pre-Market update + Trump sets 35% tariff on Canada

NEW YORK, July 11, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on July 11th

- Advertisement -
  • After the S&P 500 finished at a record on Thursday, equities are lower this morning following President Donald Trump’s announcement of a 35% levy on Canada beginning on August 1st.
  • President Trump said Fentanyl was the reason for the tariffs. Canadian Prime Minister Mark Carney replied on X saying, “we are committed to continuing to work with the U.S to save lives and protect communities.”
  • During the first full week of July Trade, President Trump extended the July 9th tariff deadline to August 1st. He’s added new levies as well, including some on more than a dozen countries like Japan and South Korea.

Opening Bell
FIFA and DAZN celebrate the FIFA Club World Cup 2025 Final between Chelsea FC and Paris Saint-Germain

- Advertisement -

Closing Bell
Jim Cramer and the CNBC Investing Club team celebrate the club’s 3rd annual meeting

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2729457/NYSE_Market_Update_July_11.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–trump-sets-35-tariff-on-canada-302503292.html

- Advertisement -

Recent Posts

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

10 minutes ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a…

10 minutes ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or…

10 minutes ago

Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou

GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:   As we…

11 minutes ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety…

11 minutes ago

Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million

Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share Private Placement Up to…

11 minutes ago